Sept. 23, 2022

The Multi-Billion Dollar Rx Middlemen: PBMs Explained

The Multi-Billion Dollar Rx Middlemen: PBMs Explained

Pharmacy Benefit Managers (PBMs) have become embedded in the ecosystem of drug pricing– but these middlemen are one of the reasons patients see high prices at the pharmacy counter. 

This episode is a crash course in everything drug pricing with a focus on PBMs, from their inception to their influence on health care costs. Guest Antonio Ciaccia, drug pricing researcher, explains how the key players of the drug supply chain, specifically PBMs, have impacted patients’ access to transparent health care. 

Hosts: 

Terry Wilcox, Executive Director, Patients Rising

Dr. Robert Goldberg, “Dr. Bob,” Co-Founder and Vice President of the Center for Medicine in the Public Interest

Kate Pecora, Field Correspondent

Guests: 

Antonio Ciaccia, President of 3 Axis Advisors and Chief Executive Officer of 46brooklyn Research

Kelsey Feng, Correspondent 

Links: 

46brooklyn Research

3 Axis Advisors

Why Ryan Reynolds is telling people to get a colonoscopy

Intellia's gene editing therapies

Free2Care Report

Need help?

The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands? Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.org

Have a question or comment about the show, or want to suggest a show topic or share your story as a patient correspondent?

Drop us a line: podcast@patientsrising.org

The views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising, nor do the views and opinions stated on this show reflect the opinions of a guest’s current or previous employers.